CTI BioPharma: 4Q Earnings Snapshot
The Associated Press | Hagadone News Network | UPDATED 5 years, 2 months AGO
SEATTLE (AP) _ CTI BioPharma Corp. (CTIC) on Thursday reported a fourth-quarter loss of $8.2 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Seattle-based company said it had a loss of 14 cents.
For the year, the company reported that its loss widened to $40 million, or 69 cents per share. Revenue was reported as $3.3 million.
In the final minutes of trading on Thursday, the company's shares hit 83 cents. A year ago, they were trading at 98 cents.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTIC at https://www.zacks.com/ap/CTIC
MORE IMPORTED STORIES
ARTICLES BY THE ASSOCIATED PRESS
The Latest: US helped family escape Afghanistan overland
WASHINGTON — The United States is confirming for the first time that it has helped a U.S. citizen and family members to escape Afghanistan through an overland route to a neighboring country.
The Latest: US helped family escape Afghanistan overland
WASHINGTON — The United States is confirming for the first time that it has helped a U.S. citizen and family members to escape Afghanistan through an overland route to a neighboring country.
The Latest: Top Republican says Taliban holding Americans
WASHINGTON — The top Republican on the House Foreign Affairs Committee says some Americans who have been trying to get out of Afghanistan since the U.S. military left are sitting in airplanes at an airport ready to leave but the Taliban are not letting them take off.